Role of Apomorphine in the Treatment of Parkinson’s Disease

Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection

(2014) Robert A. Hauser et al.   PARKINSONISM & RELATED DISORDERS

Subcutaneous apomorphine and non-motor symptoms in Parkinson's disease

(2013) Antoniya Todorova et al.   PARKINSONISM & RELATED DISORDERS

The Pharmacological Properties and Therapeutic Use of Apomorphine

(2012) Samo Ribarič   MOLECULES

TLC–surface enhanced Raman scattering of apomorphine in human plasma

(2012) Andrea Lucotti et al.   VIBRATIONAL SPECTROSCOPY

Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation

(2010) Eri Himeno et al.   ANNALS OF NEUROLOGY

Continuous subcutaneous apomorphine for severe disorders of consciousness after traumatic brain injury

(2010) Esteban A. Fridman et al.   BRAIN INJURY

Awakenings and Awareness Recovery in Disorders of Consciousness

(2010) Francesca Pistoia et al.   CNS DRUGS

Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease

(2009) Carl E. Clarke et al.   PARKINSONISM & RELATED DISORDERS

Open-Label Study Assessment of Safety and Adverse Effects of Subcutaneous Apomorphine Injections in Treating "Off" Episodes in Advanced Parkinson Disease

(2008) Peter A. LeWitt et al.   CLINICAL NEUROPHARMACOLOGY

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

(2008) Pedro J. García Ruiz et al.   MOVEMENT DISORDERS

Apomorphine for the acute treatment of “off” episodes in Parkinson's disease

(2007) Mark Stacy et al.   PARKINSONISM & RELATED DISORDERS